Format

Send to

Choose Destination
J Subst Abuse Treat. 2009 Jul;37(1):64-72. doi: 10.1016/j.jsat.2008.09.012. Epub 2008 Nov 26.

Organizational determinants of outpatient substance abuse treatment duration in women.

Author information

1
Division of Research, Kaiser Permanente, Oakland, CA 94612, USA. cynthia.i.campbell@kp.org

Abstract

Longer treatment duration has consistently been related to improved substance use outcomes. This study examined how tailored women's programming and organizational characteristics were related to duration in outpatient substance abuse treatment in women. Data were from two waves of a national outpatient substance abuse treatment unit survey (n = 571 in 1999/2000, n = 566 in 2005). Analyses were conducted separately for methadone and nonmethadone programs. Negative binomial regressions tested associations between organizational determinants, tailored programming, and women's treatment duration. Of the tailored programming services, childcare was significantly related to longer duration in the nonmethadone programs, but few other organizational factors were. Tailored programming was not associated to treatment duration in methadone programs, but ownership, affiliation, and accreditation were related to longer duration. Study findings suggest evidence for how external relationships related to resources, treatment constraints, and legitimacy may influence women's treatment duration. Methadone programs may be more vulnerable to external influences.

PMID:
19038526
PMCID:
PMC2935286
DOI:
10.1016/j.jsat.2008.09.012
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center